Home
Cataract
Cornea
Glaucoma
Refractive
Retina
Practice Management
Welcome Guest
Sign In
Register
News
Events
Articles
Product Center
Featured Products
Videos
Register
Sign In
AdGlare Leaderboard
OphthalmologyWeb
Optos: Experience the Latest in Ultra-widefield Imaging Technology
Optos: Experience the Latest in Ultra-widefield Imaging Technology
Tweet
Facebook
Email
Friday, June 20, 2014
Tweet
Optos, Inc.
<<
<
>
>>
View Transcript
Ophthalmology Videos
Cataract
Glaucoma
Refractive
Retina
Practice Management
Cornea
Ophthalmology Videos
DORC Launches EVA AVETA Trocar Cannula System
Monday, April 26, 2021
Study Suggests a Role for Citicoline in Protection Against Glaucoma
Friday, April 23, 2021
VERITAS Vision System for Phacoemulsification Receives FDA Clearance ...
Thursday, April 22, 2021
Trial Data for Intravitreal Gene Therapy for Wet AMD to Be Presented ...
Monday, April 19, 2021
Pooled Phase 2 and Phase 3 Data Published for TEPEZZA in Thyroid Eye ...
Friday, April 16, 2021
Positive Safety Profile Reported for ONS-5010 / LYTENAVA for Wet AMD
Monday, April 05, 2021
Luneau Technology USA Launches 2nd Generation Visionix® Eye Refract ...
Friday, April 02, 2021
Nanoform and Nacuity Pharmaceuticals Sign Agreement to Explore ...
Thursday, April 01, 2021
Essilor Instruments USA Launches New Vision-R 700 Refraction System
Wednesday, March 24, 2021
NIDEK Launches Control Software for RT-6100 and TS-610 Refraction ...
Tuesday, March 23, 2021
FDA Accepts New Drug Application for Presbyopia-Correcting Eye Drop
Monday, March 22, 2021
Newly Formed Ophthalmology Foundation Seeks to Improve Global Eye Care...
Friday, March 19, 2021
New Partnership to Support Commercialization of Tsert SI Implantable ...
Tuesday, March 16, 2021
Two Phase 3 Trials Announced for Intravitreal Gene Therapy in Wet AMD
Monday, March 15, 2021
Dry Eye Disease Affects Both Physical and Mental Health of Patients
Friday, March 12, 2021
Page
<<
<
11
12
13
14
15
>
>>
AdGlare RMR Ad
Video Search
Related Videos
The Future of Dry Eye and the Keratograph 5M by Dr. David Kading, OD
01:00
AdGlare RMR2